Sir, I read with interest the article entitled 'Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer'. The authors have proposed a very practical algor i t h m f o r t h e m a n a g e m e n t o f m a s s -f o r m i n g xanthogranulomatous cholecystitis (XGC), but I would like to highlight the evolving role of endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) in such cases of gall bladder masses. To overcome the limitations of percutaneous FNA and, at the same time, in order to achieve tissue diagnosis, EUS-FNA has been increasingly used in suspicious cases to differentiate gall bladder cancer (GBC) from XGC. In a study of 51 cases of gall bladder masses by Hijioka et al., 1 they found that EUS findings of disrupted gall bladder mucosal lining and/or regional lymph nodes are highly suggestive of gall bladder cancer and uncommon in XGC. EUS-FNA of these gall bladder masses or regional lymph nodes is very useful in making definitive diagnosis. The diagnostic accuracy of EUS-FNA to correctly distinguish between benign and malignant masses in their study was 93.3 % with a sensitivity and specificity of 90 and 100 %, respectively.
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